Skip to main content
. 2016 Aug 4;7(39):63177–63188. doi: 10.18632/oncotarget.11050

Figure 2. The comparison of overall survival between patients with h-MDS and NH-MDS.

Figure 2

Patients with h-MDS had a longer median overall survival than those with NH-MDS (80.5 months vs. 29.6 months, P=0.001).